Agentix (AGTX) Payables (2014 - 2026)
Agentix's (AGTX) quarterly Payables came in at $715870.0 in Q1 2026, down 26.11% YoY from $968888.0 in Q1 2025, and up 1.22% on a QoQ basis from $707215.0 in Q4 2025.
Agentix (AGTX) Payables (2014 - 2026) Analysis & Trends
Agentix (AGTX) has 13 years of Payables data on file, last reported at $715870.0 in Q1 2026.
- Quarterly Payables fell 26.11% year-over-year to $715870.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $715870.0 (down 26.11% YoY) and the FY2026 annual result came in at $715870.0, down 26.11% from the prior year.
- Payables climbed to $715870.0 in Q1 2026, from $707215.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $2.0 million in Q4 2022 to a low of $700149.0 in Q2 2025.
- A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables surged 257.98% — and 2023, when it sank 43.97%.
- Tracing AGTX's Payables over 5 years: stood at $2.0 million in 2022, then sank by 43.97% to $1.1 million in 2023, then retreated by 3.55% to $1.1 million in 2024, then slumped by 33.73% to $707215.0 in 2025, then gained by 1.22% to $715870.0 in 2026.
- The last three Payables figures came in at $715870.0 (Q1 2026), $707215.0 (Q4 2025), and $711639.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | 713,344.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 713,344.00 |
| Mar 31, 2026 | 715,870.00 |
| Dec 31, 2025 | 707,215.00 |
| Sep 30, 2025 | 711,639.00 |
| Jun 30, 2025 | 700,149.00 |
| Mar 31, 2025 | 968,888.00 |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 961,661.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Feb 28, 2022 | 1.04 Mn |
| Nov 30, 2021 | 773,060.00 |
| Aug 31, 2021 | 606,842.00 |